VRB news

Latest 1 stories · newest Nov 12, 2026

VRB

Vor Biopharma issues Pre-Funded Warrants to RemeGen

Vor Biopharma agreed to issue Pre-Funded Warrants to RemeGen for up to 2.3 million shares as consideration under a Securities Purchase and License Agreement. The event impacts the company’s capital structure and cap table.

Offering Nov 12, 2026 sentiment -0.40 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same VRB feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/VRB/newsSTART FREE